Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-15-000035

CEO bought 142,550 shares at an average $0.15 ($21,024)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2015-07-23 Purchase : show line 1 in the form +27,550 $0.14 $3,829 4,634,230 D
2015-07-23 Purchase : show line 2 in the form +10,000 $0.14 $1,400 4,644,230 D
2015-07-24 Purchase : show line 3 in the form +10,000 $0.16 $1,550 4,654,230 D
2015-07-24 Purchase : show line 4 in the form +25,000 $0.15 $3,750 4,679,230 D
2015-07-24 Purchase : show line 5 in the form +20,000 $0.15 $2,998 4,699,230 D
2015-07-24 Purchase : show line 6 in the form +5,000 $0.15 $750 4,704,230 D
2015-07-24 Purchase : show line 7 in the form +10,000 $0.15 $1,499 4,714,230 D
2015-07-24 Purchase : show line 8 in the form +5,000 $0.15 $750 4,719,230 D
Open-market purchases · 142,550 sh · avg $0.15 · $21,024
Loading xslF345X03/primary_doc.xml…